GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Indoco Remedies Ltd

Indoco Remedies Ltd Schedules Board Meeting for Q1 FY27 Financial Results

BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 15 Jul 2026, 12:49 PM IST  ·  BSE ID: ff81fbe0-02d0-43f5-a45b-80f05080486e
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet soon to approve its latest financial performance report for the first quarter of this fiscal year.
🤖 AI Summary
  • Indoco Remedies board meeting set for July 28, 2026, to approve Q1 FY27 results.
  • Unaudited standalone and consolidated financial results for quarter ended June 30, 2026 to be considered.
  • Trading window for designated persons remains closed until July 30, 2026.
  • Disclosure made under Regulation 29 of SEBI LODR Regulations, 2015.
🏢 How This Affects the Company
💰
Financial Impact
The upcoming announcement of unaudited standalone and consolidated financial results will provide key performance indicators for the quarter.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Shareholders should await the release of the financial results.
👤
Who Is Affected
All shareholders are potentially affected by the company's financial performance which will be disclosed in the upcoming results.
🔍
Management Signal
The timely scheduling of the board meeting signals adherence to regulatory requirements for financial reporting.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting outcome on July 28, 2026
Release of unaudited Q1 FY27 financial results
End of trading window closure on July 30, 2026
LOW RISK The filing is a standard procedural announcement for financial results disclosure.
💡 Investor Takeaway
Indoco Remedies Ltd has scheduled a board meeting on July 28, 2026, to approve its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
❓ Frequently Asked Questions
When will Indoco Remedies Ltd announce its Q1 FY27 financial results?
Indoco Remedies Ltd will consider and approve its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, at a board meeting scheduled for July 28, 2026.
What is the purpose of the board meeting scheduled for July 28, 2026?
The board meeting of Indoco Remedies Ltd is scheduled to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
When does the trading window close for Indoco Remedies Ltd?
The trading window for dealing in equity shares of Indoco Remedies Ltd remains closed for designated persons until July 30, 2026, 48 hours after the declaration of Q1 FY27 financial results.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.